In the last 12 months, insiders at Elevance Health, Inc. ($ELV) filed 237 transactions with the SEC: 5 open-market purchases totaling $3,683,051 and 35 sales totaling $59,793,287. Net insider sentiment: net selling.
Elevance Health, Inc. operates in the Hospital & medical service plans industry (Finance sector).
Most Active Insiders
- BOUDREAUX GAIL (President and CEO) — 27 transactions totaling $45,078,058
- Haytaian Peter D (EVP & Pres Carelon & CarelonRx) — 24 transactions totaling $20,190,946
- Norwood Felicia F (EVP & President,Gov Health Ben) — 16 transactions totaling $16,103,071
- Kendrick Charles Morgan JR (EVP & President, Commercial) — 26 transactions totaling $10,930,085
- MCCARTHY GLORIA M (EVP & Chief Administrative Off) — 11 transactions totaling $9,549,845
View all SEC Filings for Elevance Health, Inc. (ELV).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | SCHULMAN AMY W | Director | S | Common Stock | 26 | $287.50 | 218.0000 | 224,600,000 | 10.66% | 0.00% |
| March 6, 2026 | Kendrick Charles Morgan JR | EVP & President, Commercial | S | Common Stock | 3196 | $284.92 | 11,791.0000 | 224,600,000 | 21.33% | 0.00% |
| March 5, 2026 | COLLIS STEVEN H | Director | P | Common Stock | 3000 | $289.84 | 3,639.0000 | 224,600,000 | 469.48% | 0.00% |
| March 2, 2026 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | A | Common Stock | 6802 | $0.00 | 16,371.0000 | 224,600,000 | 71.08% | 0.00% |
| March 2, 2026 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | A | Common Stock | 5101 | $0.00 | 9,569.0000 | 224,600,000 | 114.17% | 0.00% |
| March 2, 2026 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | F | Common Stock | 315 | $294.07 | 4,468.0000 | 224,600,000 | 6.59% | 0.00% |
| March 2, 2026 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | A | Employee Stock Option (Right to Buy) | 23512 | $0.00 | 23,512.0000 | 224,600,000 | 9999.99% | 0.01% |
| March 3, 2026 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | F | Common Stock | 496 | $284.03 | 38,838.0000 | 224,600,000 | 1.26% | 0.00% |
| March 2, 2026 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | A | Common Stock | 2865 | $0.00 | 39,334.0000 | 224,600,000 | 7.86% | 0.00% |
| March 2, 2026 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | A | Common Stock | 5951 | $0.00 | 36,469.0000 | 224,600,000 | 19.50% | 0.00% |
| March 2, 2026 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | F | Common Stock | 1421 | $294.07 | 30,518.0000 | 224,600,000 | 4.45% | 0.00% |
| March 2, 2026 | Craig Ryan R | EVP & Chief HR Officer | A | Employee Stock Option (Right to Buy) | 11754 | $0.00 | 11,754.0000 | 224,600,000 | 9999.99% | 0.01% |
| March 3, 2026 | Craig Ryan R | EVP & Chief HR Officer | F | Common Stock | 309 | $284.03 | 6,674.0000 | 224,600,000 | 4.43% | 0.00% |
| March 2, 2026 | Craig Ryan R | EVP & Chief HR Officer | A | Common Stock | 2976 | $0.00 | 6,983.0000 | 224,600,000 | 74.27% | 0.00% |
| March 2, 2026 | Craig Ryan R | EVP & Chief HR Officer | F | Common Stock | 25 | $294.07 | 4,007.0000 | 224,600,000 | 0.62% | 0.00% |
| March 2, 2026 | Wessling Erin M | EVP & Chief Legal Officer | A | Employee Stock Option (Right to Buy) | 11754 | $0.00 | 11,754.0000 | 224,600,000 | 9999.99% | 0.01% |
| March 2, 2026 | Kendrick Charles Morgan JR | EVP & President, Commercial | F | Common Stock | 1211 | $294.07 | 8,905.0000 | 224,600,000 | 11.97% | 0.00% |
| March 2, 2026 | Wessling Erin M | EVP & Chief Legal Officer | A | Common Stock | 2976 | $0.00 | 7,996.0000 | 224,600,000 | 59.28% | 0.00% |
| March 3, 2026 | Wessling Erin M | EVP & Chief Legal Officer | F | Common Stock | 417 | $284.03 | 7,579.0000 | 224,600,000 | 5.22% | 0.00% |
| March 2, 2026 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | A | Employee Stock Option (Right to Buy) | 20152 | $0.00 | 20,152.0000 | 224,600,000 | 9999.99% | 0.01% |
| March 3, 2026 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | F | Common Stock | 222 | $284.03 | 16,149.0000 | 224,600,000 | 1.36% | 0.00% |
| March 2, 2026 | BOUDREAUX GAIL | President and CEO | A | Employee Stock Option (Right to Buy) | 63818 | $0.00 | 63,818.0000 | 224,600,000 | 9999.99% | 0.03% |
| March 3, 2026 | BOUDREAUX GAIL | President and CEO | F | Common Stock | 1736 | $284.03 | 169,311.0000 | 224,600,000 | 1.01% | 0.00% |
| March 2, 2026 | BOUDREAUX GAIL | President and CEO | A | Common Stock | 10527 | $0.00 | 171,047.0000 | 224,600,000 | 6.56% | 0.00% |
| March 2, 2026 | BOUDREAUX GAIL | President and CEO | A | Common Stock | 16153 | $0.00 | 160,520.0000 | 224,600,000 | 11.19% | 0.01% |
| March 2, 2026 | BOUDREAUX GAIL | President and CEO | F | Common Stock | 6713 | $294.07 | 144,367.0000 | 224,600,000 | 4.44% | 0.00% |
| March 2, 2026 | Kaye Mark | EVP & CFO | A | Employee Stock Option (Right to Buy) | 25188 | $0.00 | 25,188.0000 | 224,600,000 | 9999.99% | 0.01% |
| March 3, 2026 | Kaye Mark | EVP & CFO | F | Common Stock | 353 | $284.03 | 32,037.0000 | 224,600,000 | 1.09% | 0.00% |
| March 2, 2026 | Kaye Mark | EVP & CFO | A | Common Stock | 10202 | $0.00 | 32,390.0000 | 224,600,000 | 45.98% | 0.00% |
| March 2, 2026 | Kaye Mark | EVP & CFO | A | Common Stock | 6377 | $0.00 | 22,188.0000 | 224,600,000 | 40.33% | 0.00% |
| March 2, 2026 | Kaye Mark | EVP & CFO | F | Common Stock | 271 | $294.07 | 15,811.0000 | 224,600,000 | 1.69% | 0.00% |
| March 3, 2026 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 446 | $284.03 | 27,222.0000 | 224,600,000 | 1.61% | 0.00% |
| March 2, 2026 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 2865 | $0.00 | 27,668.0000 | 224,600,000 | 11.55% | 0.00% |
| March 2, 2026 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 1201 | $294.07 | 24,803.0000 | 224,600,000 | 4.62% | 0.00% |
| March 2, 2026 | Penczek Ronald W | CAO & Controller | A | Employee Stock Option (Right to Buy) | 1677 | $0.00 | 1,677.0000 | 224,600,000 | 9999.99% | 0.00% |
| March 3, 2026 | Penczek Ronald W | CAO & Controller | F | Common Stock | 37 | $284.03 | 4,099.0000 | 224,600,000 | 0.89% | 0.00% |
| March 2, 2026 | Penczek Ronald W | CAO & Controller | A | Common Stock | 266 | $0.00 | 4,136.0000 | 224,600,000 | 6.87% | 0.00% |
| March 2, 2026 | Penczek Ronald W | CAO & Controller | A | Common Stock | 1701 | $0.00 | 3,870.0000 | 224,600,000 | 78.42% | 0.00% |
| March 2, 2026 | Penczek Ronald W | CAO & Controller | A | Common Stock | 426 | $0.00 | 2,169.0000 | 224,600,000 | 24.44% | 0.00% |
| March 2, 2026 | Penczek Ronald W | CAO & Controller | F | Common Stock | 131 | $294.07 | 1,743.0000 | 224,600,000 | 6.99% | 0.00% |
| March 2, 2026 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Employee Stock Option (Right to Buy) | 15870 | $0.00 | 15,870.0000 | 224,600,000 | 9999.99% | 0.01% |
| March 3, 2026 | Kendrick Charles Morgan JR | EVP & President, Commercial | F | Common Stock | 467 | $284.03 | 14,987.0000 | 224,600,000 | 3.02% | 0.00% |
| March 2, 2026 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 2532 | $0.00 | 15,454.0000 | 224,600,000 | 19.59% | 0.00% |
| March 2, 2026 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 4017 | $0.00 | 12,922.0000 | 224,600,000 | 45.11% | 0.00% |
| Feb. 2, 2026 | SCHULMAN AMY W | Director | A | Common Stock | 218 | $0.00 | 218.0000 | 224,600,000 | 9999.99% | 0.00% |
| Feb. 2, 2026 | Craig Ryan R | EVP & Chief HR Officer | F | Common Stock | 279 | $341.83 | 4,032.0000 | 224,600,000 | 6.47% | 0.00% |
| Oct. 2, 2025 | Kaye Mark | EVP & CFO | F | Common Stock | 2895 | $340.24 | 16,082.0000 | 225,600,000 | 15.26% | 0.00% |
| Sept. 3, 2025 | Wessling Erin M | EVP & Chief Legal Officer | F | Common Stock | 152 | $321.59 | 5,020.0000 | 232,900,000 | 2.94% | 0.00% |
| Sept. 2, 2025 | Wessling Erin M | EVP & Chief Legal Officer | A | Employee Stock Option (Right to Buy) | 3541 | $0.00 | 3,541.0000 | 232,900,000 | 9999.99% | 0.00% |
| Sept. 2, 2025 | Wessling Erin M | EVP & Chief Legal Officer | A | Common Stock | 931 | $0.00 | 5,172.0000 | 232,900,000 | 21.95% | 0.00% |
| Sept. 2, 2025 | Craig Ryan R | EVP & Chief HR Officer | A | Employee Stock Option (Right to Buy) | 3690 | $0.00 | 3,690.0000 | 232,900,000 | 9999.99% | 0.00% |
| Sept. 2, 2025 | Craig Ryan R | EVP & Chief HR Officer | A | Common Stock | 970 | $0.00 | 5,353.0000 | 232,900,000 | 22.13% | 0.00% |
| Aug. 19, 2025 | DeVore Susan D. | Director | P | Common Stock | 1200 | $312.15 | 3,502.0000 | 232,900,000 | 52.13% | 0.00% |
| Aug. 1, 2025 | COLLIS STEVEN H | Director | A | Common Stock | 639 | $0.00 | 639.0000 | 232,900,000 | 9999.99% | 0.00% |
| July 18, 2025 | BOUDREAUX GAIL | President and CEO | P | Common Stock | 2334 | $286.07 | 144,914.0000 | 232,900,000 | 1.64% | 0.00% |
| July 18, 2025 | BOUDREAUX GAIL | President and CEO | P | Common Stock | 1050 | $287.96 | 151,080.0000 | 232,900,000 | 0.70% | 0.00% |
| July 18, 2025 | BOUDREAUX GAIL | President and CEO | P | Common Stock | 5116 | $287.12 | 150,030.0000 | 232,900,000 | 3.53% | 0.00% |
| May 14, 2025 | DeVore Susan D. | Director | A | Common Stock | 601 | $0.00 | 2,302.0000 | 232,900,000 | 35.33% | 0.00% |
| May 14, 2025 | Dixon Robert L JR | Director | A | Common Stock | 601 | $0.00 | 10,322.0000 | 232,900,000 | 6.18% | 0.00% |
| May 14, 2025 | CLARK R KERRY | Director | A | Common Stock | 601 | $0.00 | 9,640.0000 | 232,900,000 | 6.65% | 0.00% |
| May 14, 2025 | STRABLE-SOETHOUT DEANNA D | Director | A | Common Stock | 601 | $0.00 | 1,646.0000 | 232,900,000 | 57.51% | 0.00% |
| May 14, 2025 | Schneider Ryan M. | Director | A | Common Stock | 601 | $0.00 | 6,600.0000 | 232,900,000 | 10.02% | 0.00% |
| May 14, 2025 | PERU RAMIRO G | Director | A | Common Stock | 601 | $0.00 | 9,345.0000 | 232,900,000 | 6.87% | 0.00% |
| May 14, 2025 | Neri Antonio F | Director | A | Common Stock | 601 | $0.00 | 4,925.0000 | 232,900,000 | 13.90% | 0.00% |
| May 14, 2025 | Jallal Bahija | Director | A | Common Stock | 601 | $0.00 | 4,788.0000 | 232,900,000 | 14.35% | 0.00% |
| May 14, 2025 | HAY LEWIS III | Director | A | Common Stock | 601 | $0.00 | 11,507.0000 | 232,900,000 | 5.51% | 0.00% |
| April 24, 2025 | Kaye Mark | EVP & CFO | S | Common Stock | 4588 | $424.82 | 18,977.0000 | 232,900,000 | 19.47% | 0.00% |
| March 10, 2025 | Penczek Ronald W | CAO & Controller | S | Common Stock | 443 | $415.13 | 1,847.0000 | 232,900,000 | 19.34% | 0.00% |
| March 3, 2025 | Norwood Felicia F | EVP & President,Gov Health Ben | A | Common Stock | 3035 | $0.00 | 27,726.0000 | 232,900,000 | 12.29% | 0.00% |
| March 3, 2025 | Kendrick Charles Morgan JR | EVP & President, Commercial | F | Common Stock | 2221 | $395.50 | 7,089.0000 | 232,900,000 | 23.86% | 0.00% |
| March 3, 2025 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 2845 | $0.00 | 9,934.0000 | 232,900,000 | 40.13% | 0.00% |
| March 3, 2025 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 3686 | $0.00 | 13,620.0000 | 232,900,000 | 37.10% | 0.00% |
| March 5, 2025 | Kendrick Charles Morgan JR | EVP & President, Commercial | S | Common Stock | 3504 | $396.30 | 10,116.0000 | 232,900,000 | 25.73% | 0.00% |
| March 3, 2025 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Employee Stock Option (Right to Buy) | 10828 | $0.00 | 10,828.0000 | 232,900,000 | 9999.99% | 0.00% |
| March 3, 2025 | Penczek Ronald W | CAO & Controller | F | Common Stock | 198 | $395.50 | 1,584.0000 | 232,900,000 | 11.11% | 0.00% |
| March 3, 2025 | Penczek Ronald W | CAO & Controller | A | Common Stock | 285 | $0.00 | 1,869.0000 | 232,900,000 | 17.99% | 0.00% |
| March 3, 2025 | Penczek Ronald W | CAO & Controller | A | Common Stock | 421 | $0.00 | 2,290.0000 | 232,900,000 | 22.53% | 0.00% |
| March 3, 2025 | Penczek Ronald W | CAO & Controller | A | Employee Stock Option (Right to Buy) | 1081 | $0.00 | 1,081.0000 | 232,900,000 | 9999.99% | 0.00% |
| March 3, 2025 | LAVU RATNAKAR | EVP, Chief Digital & Info Off | F | Common Stock | 312 | $395.50 | 2,444.0000 | 232,900,000 | 11.32% | 0.00% |
| March 3, 2025 | LAVU RATNAKAR | EVP, Chief Digital & Info Off | A | Common Stock | 2339 | $0.00 | 4,783.0000 | 232,900,000 | 95.70% | 0.00% |
| March 3, 2025 | LAVU RATNAKAR | EVP, Chief Digital & Info Off | A | Employee Stock Option (Right to Buy) | 8902 | $0.00 | 8,902.0000 | 232,900,000 | 9999.99% | 0.00% |
| March 3, 2025 | Norwood Felicia F | EVP & President,Gov Health Ben | F | Common Stock | 2613 | $395.50 | 24,691.0000 | 232,900,000 | 9.57% | 0.00% |
| March 3, 2025 | Norwood Felicia F | EVP & President,Gov Health Ben | A | Common Stock | 4213 | $0.00 | 31,939.0000 | 232,900,000 | 15.20% | 0.00% |
| March 3, 2025 | Norwood Felicia F | EVP & President,Gov Health Ben | A | Employee Stock Option (Right to Buy) | 11549 | $0.00 | 11,549.0000 | 232,900,000 | 9999.99% | 0.00% |
| March 3, 2025 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 2281 | $395.50 | 18,756.0000 | 232,900,000 | 10.84% | 0.00% |
| March 3, 2025 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 3035 | $0.00 | 21,791.0000 | 232,900,000 | 16.18% | 0.00% |
| March 3, 2025 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 4213 | $0.00 | 26,004.0000 | 232,900,000 | 19.33% | 0.00% |
| March 3, 2025 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Employee Stock Option (Right to Buy) | 11549 | $0.00 | 11,549.0000 | 232,900,000 | 9999.99% | 0.00% |
| March 3, 2025 | Kaye Mark | EVP & CFO | F | Common Stock | 270 | $395.50 | 19,961.0000 | 232,900,000 | 1.33% | 0.00% |
| March 3, 2025 | Kaye Mark | EVP & CFO | A | Common Stock | 3604 | $0.00 | 23,565.0000 | 232,900,000 | 18.06% | 0.00% |
| March 3, 2025 | Kaye Mark | EVP & CFO | A | Employee Stock Option (Right to Buy) | 13713 | $0.00 | 13,713.0000 | 232,900,000 | 9999.99% | 0.01% |
| March 3, 2025 | BOUDREAUX GAIL | President and CEO | F | Common Stock | 10396 | $395.50 | 116,373.0000 | 232,900,000 | 8.20% | 0.00% |
| March 3, 2025 | BOUDREAUX GAIL | President and CEO | A | Common Stock | 10620 | $0.00 | 126,993.0000 | 232,900,000 | 9.13% | 0.00% |
| March 3, 2025 | BOUDREAUX GAIL | President and CEO | A | Common Stock | 15587 | $0.00 | 142,580.0000 | 232,900,000 | 12.27% | 0.01% |
| March 3, 2025 | BOUDREAUX GAIL | President and CEO | A | Employee Stock Option (Right to Buy) | 40429 | $0.00 | 40,429.0000 | 232,900,000 | 9999.99% | 0.02% |
| Dec. 1, 2023 | Todt Blair Williams | EVP, CLO & CAO | F | Common Stock | 1127 | $483.12 | 16,029.0000 | 242,800,000 | 6.57% | 0.00% |
| Jan. 3, 2025 | Todt Blair Williams | EVP, CLO & CAO | F | Common Stock | 398 | $371.56 | 15,631.0000 | 232,900,000 | 2.48% | 0.00% |
| Nov. 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 1710 | $0.00 | 9,287.0000 | 233,600,000 | 22.57% | 0.00% |
| Nov. 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | F | Common Stock | 846 | $414.01 | 7,577.0000 | 233,600,000 | 10.04% | 0.00% |
| Nov. 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 3799 | $0.00 | 21,037.0000 | 233,600,000 | 22.04% | 0.00% |
| Nov. 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 1649 | $414.01 | 17,238.0000 | 233,600,000 | 8.73% | 0.00% |
| Oct. 18, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | S | Common Stock | 7417 | $432.14 | 8,423.0000 | 233,600,000 | 46.82% | 0.00% |
| Oct. 2, 2024 | Kaye Mark | EVP & CFO | F | Common Stock | 2818 | $505.16 | 20,213.0000 | 233,600,000 | 12.24% | 0.00% |
| Aug. 5, 2024 | PERU RAMIRO G | Director | S | Common Stock | 753 | $531.52 | 8,744.0000 | 237,400,000 | 7.93% | 0.00% |
| July 22, 2024 | BOUDREAUX GAIL | President and CEO | S | Common Stock | 6621 | $501.40 | 132,269.0000 | 237,400,000 | 4.77% | 0.00% |
| July 22, 2024 | BOUDREAUX GAIL | President and CEO | S | Common Stock | 2250 | $502.23 | 130,019.0000 | 237,400,000 | 1.70% | 0.00% |
| July 22, 2024 | BOUDREAUX GAIL | President and CEO | S | Common Stock | 1000 | $503.67 | 129,019.0000 | 237,400,000 | 0.77% | 0.00% |
| July 22, 2024 | BOUDREAUX GAIL | President and CEO | S | Common Stock | 2250 | $504.27 | 126,769.0000 | 237,400,000 | 1.74% | 0.00% |
| July 22, 2024 | BOUDREAUX GAIL | President and CEO | S | Common Stock | 1100 | $498.50 | 159,669.0000 | 237,400,000 | 0.68% | 0.00% |
| July 22, 2024 | BOUDREAUX GAIL | President and CEO | S | Common Stock | 20779 | $500.36 | 138,890.0000 | 237,400,000 | 13.01% | 0.01% |
| July 19, 2024 | Dixon Robert L JR | Director | S | Common Stock | 305 | $506.76 | 9,721.0000 | 237,400,000 | 3.04% | 0.00% |
| May 15, 2024 | CLARK R KERRY | Director | A | Common Stock | 388 | $0.00 | 9,039.0000 | 237,400,000 | 4.49% | 0.00% |
| May 15, 2024 | Dixon Robert L JR | Director | A | Common Stock | 388 | $0.00 | 10,026.0000 | 237,400,000 | 4.03% | 0.00% |
| May 15, 2024 | HAY LEWIS III | Director | A | Common Stock | 388 | $0.00 | 10,906.0000 | 237,400,000 | 3.69% | 0.00% |
| May 15, 2024 | Jallal Bahija | Director | A | Common Stock | 388 | $0.00 | 4,187.0000 | 237,400,000 | 10.21% | 0.00% |
| May 15, 2024 | Neri Antonio F | Director | A | Common Stock | 388 | $0.00 | 4,324.0000 | 237,400,000 | 9.86% | 0.00% |
| May 15, 2024 | PERU RAMIRO G | Director | A | Common Stock | 388 | $0.00 | 9,497.0000 | 237,400,000 | 4.26% | 0.00% |
| May 15, 2024 | Schneider Ryan M. | Director | A | Common Stock | 388 | $0.00 | 5,999.0000 | 237,400,000 | 6.91% | 0.00% |
| May 15, 2024 | STRABLE-SOETHOUT DEANNA D | Director | A | Common Stock | 388 | $0.00 | 1,045.0000 | 237,400,000 | 59.06% | 0.00% |
| May 15, 2024 | Tallett Elizabeth E | Director | A | Common Stock | 388 | $0.00 | 10,291.0000 | 237,400,000 | 3.92% | 0.00% |
| May 15, 2024 | DeVore Susan D. | Director | A | Common Stock | 388 | $0.00 | 1,701.0000 | 237,400,000 | 29.55% | 0.00% |
| April 23, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | S | Common Stock | 14011 | $533.73 | 31,560.0000 | 237,400,000 | 30.75% | 0.01% |
| April 23, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | S | Common Stock | 100 | $534.74 | 31,460.0000 | 237,400,000 | 0.32% | 0.00% |
| April 24, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | M | Common Stock | 2043 | $238.27 | 33,503.0000 | 237,400,000 | 6.49% | 0.00% |
| April 24, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | S | Common Stock | 2765 | $532.14 | 30,738.0000 | 237,400,000 | 8.25% | 0.00% |
| April 24, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | S | Common Stock | 3434 | $532.68 | 27,304.0000 | 237,400,000 | 11.17% | 0.00% |
| April 23, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | M | Employee Stock Option (right to buy) | 5473 | $0.00 | 2,043.0000 | 237,400,000 | 72.82% | 0.00% |
| April 24, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | M | Employee Stock Option (right to buy) | 2043 | $0.00 | 0.0000 | 237,400,000 | 100.00% | 0.00% |
| April 23, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | M | Common Stock | 5473 | $238.27 | 45,571.0000 | 237,400,000 | 13.65% | 0.00% |
| March 8, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | S | Common Stock | 2432 | $500.46 | 15,840.0000 | 237,400,000 | 13.31% | 0.00% |
| March 6, 2024 | Penczek Ronald W | CAO & Controller | S | Common Stock | 916 | $504.58 | 1,764.0000 | 237,400,000 | 34.18% | 0.00% |
| March 1, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | A | Common Stock | 2405 | $0.00 | 30,946.0000 | 237,400,000 | 8.43% | 0.00% |
| March 1, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | A | Common Stock | 9152 | $0.00 | 40,098.0000 | 237,400,000 | 29.57% | 0.00% |
| March 1, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | A | Employee Stock Option (Right to Buy) | 9280 | $0.00 | 9,280.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 4314 | $499.11 | 13,425.0000 | 237,400,000 | 24.32% | 0.00% |
| March 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 2405 | $0.00 | 15,830.0000 | 237,400,000 | 17.91% | 0.00% |
| March 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 9152 | $0.00 | 24,982.0000 | 237,400,000 | 57.81% | 0.00% |
| March 4, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | M | Common Stock | 15000 | $166.97 | 39,982.0000 | 237,400,000 | 60.04% | 0.01% |
| March 4, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | S | Common Stock | 4206 | $500.18 | 35,776.0000 | 237,400,000 | 10.52% | 0.00% |
| March 4, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | S | Common Stock | 1889 | $500.18 | 33,887.0000 | 237,400,000 | 5.28% | 0.00% |
| March 4, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | S | Common Stock | 15000 | $500.18 | 18,887.0000 | 237,400,000 | 44.26% | 0.01% |
| March 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Employee Stock Option (Right to Buy) | 9280 | $0.00 | 9,280.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 4, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | M | Employee Stock Option (Right to Buy) | 15000 | $0.00 | 4,908.0000 | 237,400,000 | 75.35% | 0.01% |
| March 1, 2024 | Kaye Mark | EVP & CFO | A | Common Stock | 2755 | $0.00 | 23,031.0000 | 237,400,000 | 13.59% | 0.00% |
| March 1, 2024 | Kaye Mark | EVP & CFO | A | Employee Stock Option (Right to Buy) | 10633 | $0.00 | 10,633.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 1, 2024 | BOUDREAUX GAIL | President and CEO | F | Common Stock | 19256 | $499.11 | 117,837.0000 | 237,400,000 | 14.05% | 0.01% |
| March 1, 2024 | BOUDREAUX GAIL | President and CEO | A | Common Stock | 8415 | $0.00 | 126,252.0000 | 237,400,000 | 7.14% | 0.00% |
| March 1, 2024 | BOUDREAUX GAIL | President and CEO | A | Common Stock | 34517 | $0.00 | 160,769.0000 | 237,400,000 | 27.34% | 0.01% |
| March 1, 2024 | BOUDREAUX GAIL | President and CEO | A | Employee Stock Option (Right to Buy) | 32480 | $0.00 | 32,480.0000 | 237,400,000 | 9999.99% | 0.01% |
| March 1, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | F | Common Stock | 4902 | $499.11 | 28,541.0000 | 237,400,000 | 14.66% | 0.00% |
| March 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Employee Stock Option (Right to Buy) | 8312 | $0.00 | 8,312.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 2354 | $0.00 | 18,272.0000 | 237,400,000 | 14.79% | 0.00% |
| March 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 2154 | $0.00 | 15,918.0000 | 237,400,000 | 15.65% | 0.00% |
| March 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | F | Common Stock | 1484 | $499.11 | 13,764.0000 | 237,400,000 | 9.73% | 0.00% |
| March 1, 2024 | LAVU RATNAKAR | EVP & Chief Digital Officer | A | Employee Stock Option (Right to Buy) | 6765 | $0.00 | 6,765.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 1, 2024 | LAVU RATNAKAR | EVP & Chief Digital Officer | A | Common Stock | 1002 | $0.00 | 2,756.0000 | 237,400,000 | 57.13% | 0.00% |
| March 1, 2024 | LAVU RATNAKAR | EVP & Chief Digital Officer | A | Common Stock | 1754 | $0.00 | 1,754.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 1, 2024 | Todt Blair Williams | EVP, CLO & CAO | A | Employee Stock Option (Right to Buy) | 8312 | $0.00 | 8,312.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 1, 2024 | Todt Blair Williams | EVP, CLO & CAO | A | Common Stock | 6537 | $0.00 | 17,156.0000 | 237,400,000 | 61.56% | 0.00% |
| March 1, 2024 | Todt Blair Williams | EVP, CLO & CAO | A | Common Stock | 2154 | $0.00 | 10,619.0000 | 237,400,000 | 25.45% | 0.00% |
| March 1, 2024 | Todt Blair Williams | EVP, CLO & CAO | F | Common Stock | 3650 | $499.11 | 8,465.0000 | 237,400,000 | 30.13% | 0.00% |
| March 1, 2024 | Penczek Ronald W | CAO & Controller | A | Employee Stock Option (Right to Buy) | 867 | $0.00 | 867.0000 | 237,400,000 | 9999.99% | 0.00% |
| March 1, 2024 | Penczek Ronald W | CAO & Controller | A | Common Stock | 1046 | $0.00 | 2,680.0000 | 237,400,000 | 64.01% | 0.00% |
| March 1, 2024 | Penczek Ronald W | CAO & Controller | A | Common Stock | 226 | $0.00 | 1,634.0000 | 237,400,000 | 16.05% | 0.00% |
| March 1, 2024 | Penczek Ronald W | CAO & Controller | F | Common Stock | 383 | $499.11 | 1,408.0000 | 237,400,000 | 21.38% | 0.00% |
| Feb. 7, 2024 | PERU RAMIRO G | Director | S | Common Stock | 753 | $500.00 | 9,109.0000 | 237,400,000 | 7.64% | 0.00% |
| Jan. 3, 2024 | Todt Blair Williams | EVP, CLO & CAO | F | Common Stock | 397 | $480.49 | 12,115.0000 | 237,400,000 | 3.17% | 0.00% |
| Dec. 14, 2023 | Todt Blair Williams | EVP, CLO & CAO | M | Employee Stock Option (Right to Buy) | 5492 | $0.00 | 2,746.0000 | 242,800,000 | 66.67% | 0.00% |
| Dec. 14, 2023 | Todt Blair Williams | EVP, CLO & CAO | S | Common Stock | 5492 | $484.02 | 12,512.0000 | 242,800,000 | 30.50% | 0.00% |
| Dec. 14, 2023 | Todt Blair Williams | EVP, CLO & CAO | M | Common Stock | 5492 | $311.48 | 18,004.0000 | 242,800,000 | 43.89% | 0.00% |
| Dec. 1, 2023 | Todt Blair Williams | EVP, CLO & CAO | F | Common Stock | 116 | $483.12 | 12,512.0000 | 242,800,000 | 0.92% | 0.00% |
| Nov. 30, 2023 | Penczek Ronald W | CAO & Controller | S | Common Stock | 1055 | $475.17 | 1,787.0000 | 242,800,000 | 37.12% | 0.00% |
| Nov. 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | F | Common Stock | 79 | $446.66 | 15,248.0000 | 242,800,000 | 0.52% | 0.00% |
| Nov. 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 154 | $446.66 | 17,739.0000 | 242,800,000 | 0.86% | 0.00% |
| Oct. 24, 2023 | Penczek Ronald W | CAO & Controller | S | Common Stock | 64 | $454.35 | 2,842.0000 | 242,800,000 | 2.20% | 0.00% |
| Oct. 2, 2023 | Kaye Mark | EVP & CFO Designate | A | Employee Stock Option (Right to Buy) | 8076 | $0.00 | 8,076.0000 | 242,800,000 | 9999.99% | 0.00% |
| Oct. 2, 2023 | Kaye Mark | EVP & CFO Designate | A | Common Stock | 2102 | $0.00 | 20,276.0000 | 242,800,000 | 11.57% | 0.00% |
| Oct. 2, 2023 | Kaye Mark | EVP & CFO Designate | A | Common Stock | 18174 | $0.00 | 18,174.0000 | 242,800,000 | 9999.99% | 0.01% |
| July 21, 2023 | Dixon Robert L JR | Director | S | Common Stock | 310 | $476.71 | 9,638.0000 | 242,800,000 | 3.12% | 0.00% |
| May 10, 2023 | CLARK R KERRY | Director | A | Common Stock | 457 | $0.00 | 8,651.0000 | 242,800,000 | 5.58% | 0.00% |
| May 10, 2023 | DeVore Susan D. | Director | A | Common Stock | 457 | $0.00 | 1,313.0000 | 242,800,000 | 53.39% | 0.00% |
| May 10, 2023 | HAY LEWIS III | Director | A | Common Stock | 457 | $0.00 | 10,518.0000 | 242,800,000 | 4.54% | 0.00% |
| May 10, 2023 | PERU RAMIRO G | Director | A | Common Stock | 457 | $0.00 | 9,862.0000 | 242,800,000 | 4.86% | 0.00% |
| May 10, 2023 | Neri Antonio F | Director | A | Common Stock | 457 | $0.00 | 3,936.0000 | 242,800,000 | 13.14% | 0.00% |
| May 10, 2023 | Dixon Robert L JR | Director | A | Common Stock | 457 | $0.00 | 9,948.0000 | 242,800,000 | 4.82% | 0.00% |
| May 10, 2023 | Schneider Ryan M. | Director | A | Common Stock | 457 | $0.00 | 5,611.0000 | 242,800,000 | 8.87% | 0.00% |
| May 10, 2023 | Jallal Bahija | Director | A | Common Stock | 457 | $0.00 | 3,799.0000 | 242,800,000 | 13.67% | 0.00% |
| May 10, 2023 | Tallett Elizabeth E | Director | A | Common Stock | 457 | $0.00 | 9,903.0000 | 242,800,000 | 4.84% | 0.00% |
| May 10, 2023 | STRABLE-SOETHOUT DEANNA D | Director | A | Common Stock | 457 | $0.00 | 657.0000 | 242,800,000 | 228.50% | 0.00% |
| March 24, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | S | Common Stock | 1800 | $443.27 | 63,633.0000 | 242,800,000 | 2.75% | 0.00% |
| March 24, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | S | Common Stock | 3625 | $446.06 | 51,435.0000 | 242,800,000 | 6.58% | 0.00% |
| March 24, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | S | Common Stock | 5573 | $445.30 | 55,060.0000 | 242,800,000 | 9.19% | 0.00% |
| March 24, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | S | Common Stock | 3000 | $444.33 | 60,633.0000 | 242,800,000 | 4.71% | 0.00% |
| March 24, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | S | Common Stock | 500 | $442.02 | 65,433.0000 | 242,800,000 | 0.76% | 0.00% |
| March 24, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | S | Common Stock | 600 | $440.78 | 65,933.0000 | 242,800,000 | 0.90% | 0.00% |
| March 9, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | S | Common Stock | 2314 | $462.22 | 15,327.0000 | 242,800,000 | 13.12% | 0.00% |
| March 1, 2023 | BOUDREAUX GAIL | President and CEO | F | Common Stock | 2471 | $469.03 | 109,240.0000 | 242,800,000 | 2.21% | 0.00% |
| March 1, 2023 | Gallina John E | EVP & Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 11782 | $0.00 | 11,782.0000 | 242,800,000 | 9999.99% | 0.00% |
| March 2, 2023 | Gallina John E | EVP & Chief Financial Officer | F | Common Stock | 4650 | $468.78 | 63,725.0000 | 242,800,000 | 6.80% | 0.00% |
| March 1, 2023 | Gallina John E | EVP & Chief Financial Officer | A | Common Stock | 9716 | $0.00 | 68,375.0000 | 242,800,000 | 16.56% | 0.00% |
| March 1, 2023 | Gallina John E | EVP & Chief Financial Officer | A | Common Stock | 3065 | $0.00 | 58,659.0000 | 242,800,000 | 5.51% | 0.00% |
| March 1, 2023 | Penczek Ronald W | CAO & Controller | A | Employee Stock Option (Right to Buy) | 819 | $0.00 | 819.0000 | 242,800,000 | 9999.99% | 0.00% |
| March 2, 2023 | Penczek Ronald W | CAO & Controller | F | Common Stock | 380 | $468.78 | 2,882.0000 | 242,800,000 | 11.65% | 0.00% |
| March 1, 2023 | Penczek Ronald W | CAO & Controller | A | Common Stock | 1195 | $0.00 | 3,262.0000 | 242,800,000 | 57.81% | 0.00% |
| March 1, 2023 | Penczek Ronald W | CAO & Controller | A | Common Stock | 214 | $0.00 | 2,067.0000 | 242,800,000 | 11.55% | 0.00% |
| March 1, 2023 | Penczek Ronald W | CAO & Controller | F | Common Stock | 64 | $469.03 | 1,853.0000 | 242,800,000 | 3.34% | 0.00% |
| March 1, 2023 | Norwood Felicia F | EVP & President, GBD | F | Common Stock | 495 | $469.03 | 26,189.0000 | 242,800,000 | 1.86% | 0.00% |
| March 1, 2023 | Norwood Felicia F | EVP & President, GBD | A | Common Stock | 2292 | $0.00 | 28,481.0000 | 242,800,000 | 8.75% | 0.00% |
| March 1, 2023 | Norwood Felicia F | EVP & President, GBD | A | Common Stock | 9716 | $0.00 | 38,197.0000 | 242,800,000 | 34.11% | 0.00% |
| March 1, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | F | Common Stock | 617 | $469.03 | 60,114.0000 | 242,800,000 | 1.02% | 0.00% |
| March 2, 2023 | Norwood Felicia F | EVP & President, GBD | F | Common Stock | 4754 | $468.78 | 33,443.0000 | 242,800,000 | 12.45% | 0.00% |
| March 1, 2023 | Norwood Felicia F | EVP & President, GBD | A | Employee Stock Option (Right to Buy) | 8812 | $0.00 | 8,812.0000 | 242,800,000 | 9999.99% | 0.00% |
| March 1, 2023 | Gallina John E | EVP & Chief Financial Officer | F | Common Stock | 587 | $469.03 | 55,594.0000 | 242,800,000 | 1.04% | 0.00% |
| March 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Employee Stock Option (Right to Buy) | 8812 | $0.00 | 8,812.0000 | 242,800,000 | 9999.99% | 0.00% |
| March 2, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 5469 | $468.78 | 17,893.0000 | 242,800,000 | 23.41% | 0.00% |
| March 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 9716 | $0.00 | 23,362.0000 | 242,800,000 | 71.20% | 0.00% |
| March 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | A | Common Stock | 2292 | $0.00 | 13,646.0000 | 242,800,000 | 20.19% | 0.00% |
| March 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | F | Common Stock | 607 | $469.03 | 11,354.0000 | 242,800,000 | 5.07% | 0.00% |
| March 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Employee Stock Option (Right to Buy) | 7786 | $0.00 | 7,786.0000 | 242,800,000 | 9999.99% | 0.00% |
| March 2, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | F | Common Stock | 1084 | $468.78 | 17,641.0000 | 242,800,000 | 5.79% | 0.00% |
| March 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 2542 | $0.00 | 18,725.0000 | 242,800,000 | 15.71% | 0.00% |
| March 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | A | Common Stock | 2026 | $0.00 | 16,183.0000 | 242,800,000 | 14.31% | 0.00% |
| March 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | F | Common Stock | 293 | $469.03 | 14,157.0000 | 242,800,000 | 2.03% | 0.00% |
| March 1, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | A | Employee Stock Option (Right to Buy) | 8195 | $0.00 | 8,195.0000 | 242,800,000 | 9999.99% | 0.00% |
| March 2, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | F | Common Stock | 5430 | $468.78 | 66,533.0000 | 242,800,000 | 7.55% | 0.00% |
| March 1, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | A | Common Stock | 9716 | $0.00 | 71,963.0000 | 242,800,000 | 15.61% | 0.00% |
| March 1, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | A | Common Stock | 2133 | $0.00 | 62,247.0000 | 242,800,000 | 3.55% | 0.00% |
| March 1, 2023 | Todt Blair Williams | EVP and Chief Legal Officer | F | Common Stock | 372 | $469.03 | 7,911.0000 | 242,800,000 | 4.49% | 0.00% |
| March 1, 2023 | Todt Blair Williams | EVP and Chief Legal Officer | A | Common Stock | 2133 | $0.00 | 10,044.0000 | 242,800,000 | 26.96% | 0.00% |
| March 1, 2023 | Todt Blair Williams | EVP and Chief Legal Officer | A | Common Stock | 2584 | $0.00 | 12,628.0000 | 242,800,000 | 25.73% | 0.00% |
| March 1, 2023 | Todt Blair Williams | EVP and Chief Legal Officer | A | Employee Stock Option (Right to Buy) | 8195 | $0.00 | 8,195.0000 | 242,800,000 | 9999.99% | 0.00% |
| March 1, 2023 | BOUDREAUX GAIL | President and CEO | A | Common Stock | 35875 | $0.00 | 153,537.0000 | 242,800,000 | 30.49% | 0.01% |
| March 2, 2023 | BOUDREAUX GAIL | President and CEO | F | Common Stock | 17614 | $468.78 | 135,923.0000 | 242,800,000 | 11.47% | 0.01% |
| March 1, 2023 | BOUDREAUX GAIL | President and CEO | A | Common Stock | 8422 | $0.00 | 117,662.0000 | 242,800,000 | 7.71% | 0.00% |
| March 1, 2023 | BOUDREAUX GAIL | President and CEO | A | Employee Stock Option (Right to Buy) | 32380 | $0.00 | 32,380.0000 | 242,800,000 | 9999.99% | 0.01% |
| Jan. 3, 2023 | Todt Blair Williams | EVP and Chief Legal Officer | A | Common Stock | 3983 | $0.00 | 8,283.0000 | 242,800,000 | 92.63% | 0.00% |
| Dec. 30, 2022 | Norwood Felicia F | EVP & President, GBD | F | Common Stock | 1754 | $512.97 | 26,684.0000 | 0 | 6.17% | 0.00% |